Has Samdeep Mouli, MD received payments from drug or device companies?

Yes. Drug and device makers reported $217,346 in general payments to Samdeep Mouli, MD across 307 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Samdeep Mouli, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Samdeep Mouli, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Samdeep Mouli, MD

Vascular & Interventional Radiology · Nashville, TNNPI 1932375565

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $142,641 of the $217,346 with a category attached, or 65.6%. Boston Scientific accounts for 66.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $83,254 and has fallen 55.5% since, to $37,030 in 2025. Among vascular & interventional radiology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$217,346in general payments, 2019–2025

Across 307 payments — averaging $707.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$145K
Siemens Medical Solutions USA, Inc.$40K
Terumo Medical Corporation$30K
Argon Medical Devices, Inc.$819
Biocompatibles, Inc.$564
Guerbet LLC$421
plus $878 from 9 others

$2,730,335in research payments, 2019–2025

Across 72 payments — averaging $37,921 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$2.3M
Siemens Medical Solutions USA, Inc.$304K
Guerbet LLC$175K

What the payments were for

Consulting fees$142,64166%
Speaking & faculty fees$44,55020%
Travel & lodging$19,5199%
Food & beverage$10,6215%
Entertainment$150%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	223	$144,552
Siemens Medical Solutions USA, Inc.	41	$39,836
Terumo Medical Corporation	24	$30,276
Argon Medical Devices, Inc.	2	$819
Biocompatibles, Inc.	1	$564
Guerbet LLC	3	$421
Cook Medical LLC	2	$264
Bard Peripheral Vascular, Inc.	2	$193
Balt USA, LLC	1	$138
BTG International Canada Inc.	1	$127
Medtronic	2	$61
Penumbra, Inc.	2	$38
Varian Medical Systems, Inc.	1	$26
W. L. Gore & Associates, Inc.	1	$20
Covidien LP	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CLINICAL TRIAL PRODUCT$33,776
Navicross$20,784
GlideWire$19,184
GENERAL - THERAPIES$17,903
TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)$17,558
Artis Q ceiling$9,489
GENERAL PAIN MANAGEMENT$9,250
GENERAL VASCULAR INTERVENTION$8,636
GLIDESHEATH SLENDER$8,500
GENERAL - IO ABLATION$6,375
HydroPearl$5,600
Optitorque$4,550
Heartrail$4,550
TheraSphere Y90 Glass Microspheres 10 GBq$4,474
Artis Q floor$4,312
OBSIDIO$2,981
GENERAL EMBOLICS$2,800
TRUSELECT$2,450
EMBOLD Fibered$1,750
THERASPHERE$1,513

How this compares

$217,346 in reported general payments places this provider in the 95th percentile of 76 vascular & interventional radiology providers in Tennessee.

See all vascular & interventional radiology providers in Tennessee →

Medicare billing

Part B allowed, 2024

$69,089

Medicare patients

166

Services billed

500

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Methylprednisolone	44	$229
Ciprofloxacin Hcl	33	$168
Tamsulosin Hcl	18	$167

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Nashville

Reed OmaryNashville$66K
David ZielskeNashville$46K
Nicholas VoutsinasNashville$16K
Ryan MullerNashville$5K
Andrew MarsalaNashville$3K
Filip BanovacNashville$3K
Ava StarNashville$2K
William BarretNashville$2K
Michelle LuschenNashville$2K
Raj BantNashville$2K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →